A detailed history of Susquehanna International Group, LLP transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 67,564 shares of SANA stock, worth $247,284. This represents 0.0% of its overall portfolio holdings.

Number of Shares
67,564
Previous 32,539 107.64%
Holding current value
$247,284
Previous $177,000 58.76%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.76 - $6.86 $131,694 - $240,271
35,025 Added 107.64%
67,564 $281,000
Q2 2024

Aug 15, 2024

SELL
$5.23 - $10.44 $140,467 - $280,397
-26,858 Reduced 45.22%
32,539 $177,000
Q1 2024

May 07, 2024

SELL
$4.2 - $11.27 $75,259 - $201,947
-17,919 Reduced 23.18%
59,397 $593,000
Q4 2023

Feb 14, 2024

SELL
$2.8 - $4.55 $487,093 - $791,527
-173,962 Reduced 69.23%
77,316 $315,000
Q3 2023

Nov 14, 2023

BUY
$3.77 - $6.23 $66,679 - $110,190
17,687 Added 7.57%
251,278 $972,000
Q2 2023

Aug 11, 2023

SELL
$3.22 - $7.53 $536,126 - $1.25 Million
-166,499 Reduced 41.62%
233,591 $1.39 Million
Q1 2023

May 16, 2023

BUY
$3.11 - $4.92 $1.07 Million - $1.69 Million
343,535 Added 607.44%
400,090 $1.31 Million
Q4 2022

Feb 14, 2023

SELL
$3.19 - $6.46 $398,255 - $806,498
-124,845 Reduced 68.82%
56,555 $223,000
Q3 2022

Nov 14, 2022

BUY
$5.58 - $9.04 $704,196 - $1.14 Million
126,200 Added 228.62%
181,400 $1.09 Million
Q2 2022

Aug 15, 2022

SELL
$4.12 - $9.35 $308,011 - $699,006
-74,760 Reduced 57.53%
55,200 $355,000
Q1 2022

May 16, 2022

BUY
$5.24 - $15.58 $263,011 - $782,006
50,193 Added 62.92%
129,960 $1.07 Million
Q4 2021

Feb 14, 2022

BUY
$15.18 - $23.15 $421,078 - $642,157
27,739 Added 53.32%
79,767 $1.24 Million
Q3 2021

Nov 15, 2021

BUY
$16.29 - $25.88 $73,728 - $117,132
4,526 Added 9.53%
52,028 $1.17 Million
Q2 2021

Aug 11, 2021

BUY
$16.65 - $32.14 $790,908 - $1.53 Million
47,502 New
47,502 $934,000

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $696M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.